Gemma D. Banham

Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis

Chenzhi Jing, Tomas Castro‐Dopico, Nathan Richoz et al. · Proceedings of the National Academy of Sciences · 2020 · 205 citations · Full text

Immunology, Renal Inflammation, Biological Therapy +21

Belimumab in kidney transplantation: an experimental medicine, randomised, placebo-controlled phase 2 trial

Gemma D. Banham, Shaun Flint, Nicholas Torpey et al. · The Lancet · 2018 · 90 citations · Full text

Placebo-controlled Phase 2, Urology, Transplantation +7

Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection

Gemma D. Banham, Davide Prezzi, Sarah K. Harford et al. · Transplantation · 2013 · 71 citations · Full text

Impaired Direct Priming of CD8 T Cells by Donor-Derived Cytomegalovirus Following Kidney Transplantation

Shazia Shabir, Baksho Kaul, Annette Pachnio et al. · Journal of the American Society of Nephrology · 2013 · 25 citations · Full text

Cell Therapy, Transplantation, Kidney Transplant +14

Hemodialysis Patients Make Long-Lived Antibodies against SARS-CoV-2 that May Be Associated with Reduced Reinfection

Gemma D. Banham, Alexandra Godlee, Sian Faustini et al. · Journal of the American Society of Nephrology · 2021 · 19 citations · Full text

Immunology, Viral Pathogenesis, Dialysis Therapy +16